| 0.6399 Data as of May 17 |  +0.0299 / +4.90%Today’s Change | 0.15 Today|||52-Week Range 1.25 | -11.15% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $8.4M |
CorMedix, Inc. 745 Route 202-206 Bridgewater New Jersey 08807 |
| Other institutional | 9.52% |
| Individual stakeholders | 11.80% |
| Mutual fund holders | 0.95% |
| Richard M. Cohen, MBA, CPA | Executive Chairman & Chief Financial Officer |
| Randy D. Milby, MBA | Chief Executive Officer & Head-Media Relations |
| Antony E. Pfaffle, MD | Director & Chief Scientific Officer |
| William J. Vanjonack, PhD | Vice President-Manufacturing & Quality Operations |
| Dilip Wadgaonkar, PhD | Head-Product Development & Manufacturing |
.
